Late-Breakers

Use the ACC.21 Online Planner and Virtual Schedule to browse sessions.

Online Planner

ACC.21 Virtual Schedule

Be among the first to hear the latest practice-changing scientific breakthroughs at ACC.21. Hear top experts debate and discuss the outcomes of the hottest trials and see how it all fits into your practice. With five Late-Breaking Clinical Trial Sessions, three Featured Clinical Research Sessions, and two LBCT Deep Dive Sessions, ACC.21 will leave you up-to-date on the newest clinical research.

Joint American College of Cardiology and Journal of the American College of Cardiology Late-Breaking Clinical Trials I
Saturday, May 15 ● 9 – 10 a.m. ET
Hot Topics Channel

  • PARADISE-MI: Prospective Arni Versus Ace Inhibitor Trial To Determine Superiority In Reducing Heart Failure Events After Myocardial Infarction
  • ADAPTABLE Study: Aspirin Dosing: A Patient-centric Trial Assessing Benefits And Long-term Effectiveness Trial
  • LAAOS III: The Left Atrial Appendage Occlusion Study III
  • Randomized Atlantis Trial: Oral Anti-xa Anticoagulation After Trans-aortic Valve Implantation For Aortic Stenosis

Featured Clinical Research I
Saturday, May 15 ● 12:15 – 1:30 p.m. ET
Hot Topics Channel

  • Results from the EXPLORER-HCM Randomized Clinical Trial: Health Status Benefits of Mavacamten In Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy
  • A Report From the NCDR LAAO Registry: One-year Clinical Outcomes Following Watchman Transcatheter Left Atrial Appendage Occlusion For Stroke Prevention In Patients With Atrial Fibrillation
  • Analysis Of Clinical Outcomes in the Node-301 Trial: Etripamil Nasal Spray Relieves Symptoms And Reduces Emergency Room Interventions In Patients With Paroxysmal Supraventricular Tachycardia (PSVT)
  • Atlantis 4d Computed Tomography Substudy: Valve Thrombosis After Transcatheter Aortic-valve Replacement
  • 30-day Results of the Triscend Study: Transfemoral Tricuspid Valve Replacement In Patients With Tricuspid Regurgitation
  • Results From the Twilight Study: Sex-Specific Outcomes In High-Risk Patients Receiving Ticagrelor With Or Without Aspirin After Percutaneous Coronary Intervention

Joint American College of Cardiology and Journal of the American Medical Association Late-Breaking Clinical Trials II
Sunday, May 16 ● 8 – 9:30 a.m. ET
Hot Topics Channel

  • Main Results From the DARE-19 Randomized Trial: Main Results From the DARE-19 Randomized Trial: Effects Of Dapagliflozin On Prevention Of Major Clinical Events And Recovery In Patients With Respiratory Failure Due To COVID-19
  • VOYAGER PAD Trial: Reductions In Total Ischemic Events With Rivaroxaban In Patients With Symptomatic Pad After Revascularization
  • A Phase 2 Trial Of The Efficacy And Safety Of Evinacumab In Patients With Severe Hypertriglyceridemia
  • REHAB-HF Trial: A Novel Physical Rehabilitation Intervention For Older Patients With Acute Decompensated Heart Failure
  • STRENGTH Trial: Relationship Between Omega-3 Fatty Acid Levels And Major Adverse Cardiovascular Outcomes In Patients With High Cardiovascular Risk
  • PRADA Trial: Prevention Of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: Long-term Follow-up Of A 2 X 2 Factorial, Randomized, Placebo-controlled, Double-blind Clinical Trial Of Candesartan And Metoprolol

Joint American College of Cardiology and New England Journal of Medicine Late-Breaking Clinical Trials III
Sunday, May 16 ● 10:45 a.m. – 12:15 p.m. ET
Hot Topics Channel

  • The FLOWER-MI Randomized Trial: Fractional Flow Reserve-guided Versus Angio-guided Multivessel Revascularization In ST-Elevation Myocardial Infarction Patients
  • A Prospective, Multicenter, Randomized, Open-label Trial To Compare Efficacy And Safety Of Clopidogrel Versus Ticagrelor In Stabilized Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention
  • Host Exam Randomized Controlled Trial: Aspirin Vs. Clopidogrel During Chronic Maintenance Monotherapy After Percutaneous Coronary Intervention
  • Late Outcomes Of A 1-hour High Sensitivity Troponin T Protocol In Suspected Acute Coronary Syndromes: A Randomized Clinical Trial
  • Randomized Sham-controlled RADIANCE-HTN TRIO Trial: Endovascular Ultrasound Renal Denervation To Treat Hypertension Resistant To A Fixed Dose Triple Medication Pill

Featured Clinical Research II
Sunday, May 16 ● 2 – 3:30 p.m. ET
Hot Topics Channel

  • SAFE-PAD Study: Initial Report From the Safety Assessment Of Femoropopliteal Endovascular Treatment With Paclitaxel-coated Devices Study
  • One-year Follow-up of the Reality Randomized Clinical Trial: Effect Of A Restrictive Vs Liberal Blood Transfusion Strategy On Major Cardiovascular Events Among Patients With Acute Myocardial Infarction And Anemia
  • World Alliance Societies Of Echocardiography COVID Study: Human Vs Machine Learning-based Echocardiography Analysis As Predictor Of Outcomes In Acute Covid-19 Patients
  • Coalition ACTION Trial: Randomized Clinical Trial To Evaluate A Routine Full Anticoagulation Strategy In Patients With Coronavirus Infection (SARS-CoV-2) Admitted To Hospital
  • Inspiration-S Double Blind Randomized Controlled Trial: Atorvastatin Versus Placebo In Critically-ill Patients With Covid-19
  • ACC 2020 Well Being Study: Impact of COVID-19 on the Global Cardiovascular Workforce

Late-Breaker Deep Dive I
Sunday, May 16 ● 4:45 – 6 p.m. ET
Clinical Pathways Channel 1

Get more insight from key clinical trials presented at ACC.21 and find out what it all means for you and your patients.

Late-Breaking Clinical Trials IV
Monday, May 17 ● 8 – 9:30 a.m. ET
Hot Topics Channel

  • Benefits Of Sodium Glucose Co-transporter-1/2 Inhibition With Sotagliflozin Across The Full Spectrum Of Ejection Fraction, Including Heart Failure With Preserved Ejection Fraction
  • Primary Results of the Connect-hf Randomized Clinical Trial: Care Optimization Through Patient And Hospital Engagement Clinical Trial For Heart Failure
  • Results of the LIFE Trial: Sacubitril/Valsartan (LCZ696) In Patients With Advanced Heart Failure And Reduced Ejection Fraction
  • Pirfenidone In Heart Failure With Preserved Ejection Fraction
  • Secondary Analysis From GALACTIC-HF: Impact Of Ejection Fraction On The Therapeutic Effect Of Omecamtiv Mecarbil In Patients With Heart Failure And Reduced Ejection Fraction

Late-Breaking Clinical Trials V
Monday, May 17 ● 10:45 a.m. – 12:15 p.m. ET
Hot Topics Channel

  • Therapeutic Hypothermia Following Out-Of-Hospital Cardiac Arrest: A Randomized Trial Comparing Mild And Moderate Therapeutic Hypothermia
  • Prague OHCA Study: Hyperinvasive Approach In Refractory Out-of-Hospital Cardiac Arrest: An Open-label Randomized Controlled Trial
  • RAFT-AF: A Randomized Ablation-based Atrial Fibrillation Rhythm Control Versus Rate Control Trial In Patients With Heart Failure And High Burden Atrial Fibrillation
  • Acute Alcohol Consumption And Discrete Atrial Fibrillation Events
  • Finerenone And New Onset Of Atrial Fibrillation Or Flutter In Patients With Chronic Kidney Disease And Type 2 Diabetes

Featured Clinical Research III
Monday, May 17 ● 12:30 – 1:45 p.m. ET
Hot Topics Channel

  • One-year Results of the American College Of Cardiology Global Heart Attack Treatment Initiative: Worldwide ST-elevation Myocardial Infarction Care
  • ISCHEMIA Trial: Impact Of Completeness Of Revascularization On Clinical Outcomes In Patients With Stable Ischemic Heart Disease Treated With An Invasive Vs. Conservative Strategy
  • Insights From the ISCHEMIA Trial: Impact Of Completeness Of Revascularization On Quality-of-life In Patients With Stable Ischemic Heart Disease
  • Tailor-Pci Randomized Clinical Trial Follow-up Study: Effect Of Genotype-guided Oral P2y12 Inhibitors Vs Conventional Clopidogrel On Long-term Ischemic Outcomes After Percutaneous Coronary Intervention
  • Effects Of Interleukin-6 Inhibition With Ziltivekimab On Biomarkers Of Inflammation Among Patients At High Risk For Atherosclerotic Events

Late-Breaker Deep Dive II
Monday, May 17 ● 2 – 3:30 p.m. ET
Hot Topics Channel

Get more insight from key clinical trials presented at ACC.21 and find out what it all means for you and your patients.

ADVERTISEMENT
ACC Logo
ACC.21 on Social Media:
                   
2021 American College of Cardiology Foundation. Visit ACC.org
Terms and Conditions Registered User Agreement Advertising and Sponsorship Policy Privacy Policy Cookie Policy Contact Us